The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Pathophysiology of Diabetic Retinopathy
Open accessAbstract
Diabetes is now regarded as an epidemic, with the population of patients expected to rise to 380 million by 2025. Tragically, this will lead to approximately 4 million people around the world losing their sight from diabetic retinopathy, the leading cause of blindness in patients aged 20 to 74 years. The risk of development and progression of diabetic retinopathy is closely associated with the type and duration of diabetes, blood glucose, blood pressure, and possibly lipids. Although landmark cross-sectional studies have confirmed the strong relationship between chronic hyperglycaemia and the development and progression of diabetic retinopathy, the underlying mechanism of how hyperglycaemia causes retinal microvascular damage remains unclear. Continued research worldwide has focussed on understanding the pathogenic mechanisms with the ultimate goal to prevent DR. The aim of this paper is to introduce the multiple interconnecting biochemical pathways that have been proposed and tested as key contributors in the development of DR, namely, increased polyol pathway, activation of protein kinase C (PKC), increased expression of growth factors such as vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1), haemodynamic changes, accelerated formation of advanced glycation endproducts (AGEs), oxidative stress, activation of the renin-angiotensin-aldosterone system (RAAS), and subclinical inflammation and capillary occlusion. New pharmacological therapies based on some of these underlying pathogenic mechanisms are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
El‐Remessy, A. B., Bartoli, M., Platt, D. H., Fulton, D. J., & Caldwell, R. B. (2004) · Journal of Cell Science · doi:10.1242/jcs.01612 · Cited by 149
RetractedThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,793
Antioxidant enzymes and human diseases
MatÉs, J. M., Pérez-Gómez, C., & De Castro, I. N. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00075-2 · Cited by 2,099
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Protein Glycation, Diabetes, and Aging
Ulrich, P. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.1 · Cited by 810
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Oxidative Stress and Diabetic Retinopathy
Kowluru, R. A., & Chan, P.-S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/43603 · Cited by 746
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Structure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F., & Levison, S. W. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00387-9 · Cited by 535
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496
Schröder, S., Palinski, W., & Schmid‐Schönbein, G. W. (1991) · PubMed Central · Cited by 479
(2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118887 · Cited by 460
Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 451
The Significance of Vascular and Neural Apoptosis to the Pathology of Diabetic Retinopathy
Barber, A. J., Gardner, T. W., & Abcouwer, S. F. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6293 · Cited by 439
Sjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61411-7 · Cited by 435
Kuppermann, B. D. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.309 · Cited by 429
GILLIES, M., SUTTER, F., SIMPSON, J., LARSSON, J., ALI, H., & ZHU, M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.065 · Cited by 425
Adamis, A. P., Shima, D. T., Yeo, K. T., Yeo, T. K., Brown, L. F., Berse, B., Damore, P. A., & Folkman, J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1671 · Cited by 404
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
Retinal neurodegeneration: early pathology in diabetes
Lieth, E., Gardner, T. W., Barber, A. J., & Antonetti, D. A. (2000) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00222.x · Cited by 360
Gao, B.-B., Clermont, A., Rook, S., Fonda, S. J., Srinivasan, V. J., Wojtkowski, M., Fujimoto, J. G., Avery, R. L., Arrigg, P. G., Bursell, S.-E., et al. (2007) · Nature Medicine · doi:10.1038/nm1534 · Cited by 357
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
Nguyen, Q. D., Tatlipinar, S., Shah, S. M., Haller, J. A., Quinlan, E., Sung, J., Zimmer-Galler, I., Do, D. V., & Campochiaro, P. A. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.068 · Cited by 351
Epidemiology of proliferative diabetic retinopathy
Klein, R., Klein, B. E. K., & Moss, S. E. (1992) · Diabetes Care · doi:10.2337/diacare.15.12.1875 · Cited by 344
Retinal blood flow in diabetic retinopathy.
Patel, V., Rassam, S., Newsom, R., Wiek, J., & KOHNER, E. M. (1992) · BMJ · doi:10.1136/bmj.305.6855.678 · Cited by 333
Self-citationPKD at the crossroads of DAG and PKC signaling
Wang, Q. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.003 · Cited by 331
Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus
Gabbay, K. H. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.002513 · Cited by 329
Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina
Park, S.-H., Park, J.-W., Park, S.-J., Kim, K.-Y., Chung, J.-W., Chun, M.-H., & Oh, S.-J. (2003) · Diabetologia · doi:10.1007/s00125-003-1177-6 · Cited by 322
Chun, D. W., Heier, J. S., Topping, T. M., Duker, J. S., & Bankert, J. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.033 · Cited by 295
Doganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Diabetes-Induced Mitochondrial Dysfunction in the Retina
Kowluru, R. A., & Abbas, S. N. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0353 · Cited by 288
Kowluru, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.818 · Cited by 282
Experimental Galactosemia Produces Diabetic-like Retinopathy
Engerman, R. L., & Kern, T. S. (1984) · Diabetes · doi:10.2337/diab.33.1.97 · Cited by 278
Otani, A., Takagi, H., Suzuma, K., & Honda, Y. (1998) · Circulation Research · doi:10.1161/01.res.82.5.619 · Cited by 266
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)
JORGE, R., COSTA, R. A., CALUCCI, D., CINTRA, L. P., & SCOTT, I. U. (2006) · Retina · doi:10.1097/01.iae.0000246884.76018.63 · Cited by 258
AGEs, RAGE, and Diabetic Retinopathy
Zong, H., Ward, M., & Stitt, A. W. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0198-7 · Cited by 252
Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.012 · Cited by 244
Vascular endothelial growth factor and diabetic complications
WIROSTKO, B., WONG, T., & SIMO, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241
Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works
Peppa, M., Uribarri, J., & Vlassara, H. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.186 · Cited by 234
Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Oates, P. (2008) · Current Drug Targets · doi:10.2174/138945008783431781 · Cited by 231
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher, Z., Park, Y. S., Asnaghi, V., Hoehn, T., Gerhardinger, C., & Lorenzi, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2404 · Cited by 231
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
Simó, R., & Hernández, C. (2008) · Diabetologia · doi:10.1007/s00125-008-0989-9 · Cited by 228
Meyer-Schwickerath, R., Pfeiffer, A., Blum, W. F., Freyberger, H., Klein, M., Lösche, C., Röllmann, R., & Schatz, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116877 · Cited by 224
Hypertension, diabetes, and longitudinal changes in intraocular pressure
Hennis, A., Wu, S.-Y., Nemesure, B., & Leske, M. C. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00075-7 · Cited by 219
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study
van Hecke, M. V., Dekker, J. M., Nijpels, G., Moll, A. C., Heine, R. J., Bouter, L. M., Polak, B. C. P., & Stehouwer, C. D. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1799-y · Cited by 219
Identification of Fructose 3-Phosphate in the Lens of Diabetic Rats
Szwergold, B. S., Kappler, F., & Brown, T. R. (1990) · Science · doi:10.1126/science.2300805 · Cited by 213
Cheung, A. K. H., Fung, M. K. L., Lo, A. C. Y., Lam, T. T. L., So, K. F., Chung, S. S. M., & Chung, S. K. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3119 · Cited by 207
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H.-P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Obrosova, I. G., Minchenko, A. G., Vasupuram, R., White, L., Abatan, O. I., Kumagai, A. K., Frank, R. N., & Stevens, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.3.864 · Cited by 201
Aldose reductase inhibitors: therapeutic implications for diabetic complications
Oates, P. J., & Mylari, B. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2095 · Cited by 197
Role of Glycation in Modification of Lens Crystallins in Diabetic and Nondiabetic Senile Cataracts
Lyons, T. J., Silvestri, G., Dunn, J. A., Dyer, D. G., & Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.8.1010 · Cited by 197
Oxidative Stress in Type 1 Diabetes
HASKINS, K., BRADLEY, B., POWERS, K., FADOK, V., FLORES, S., LING, X., PUGAZHENTHI, S., REUSCH, J., & KENCH, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.006 · Cited by 190
Hernández, C., Segura, R. M., Fonollosa, A., Carrasco, E., Francisco, G., & Simó, R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01538.x · Cited by 188
Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid.
Lutty, G. A., Cao, J. A., & McLeod, D. S. (1997) · PubMed · Cited by 187
Etiology and Prevalence of Hypertension in Diabetic Patients
Simonson, D. C. (1988) · Diabetes Care · doi:10.2337/diacare.11.10.821 · Cited by 179
Rangasamy, S., Srinivasan, R., Maestas, J., McGuire, P. G., & Das, A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6386 · Cited by 177
Kern, T. S., Miller, C. M., Du, Y., Zheng, L., Mohr, S., Ball, S. L., Kim, M., Jamison, J. A., & Bingaman, D. P. (2007) · Diabetes · doi:10.2337/db05-1621 · Cited by 177
Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease
Ruberte, J., Ayuso, E., Navarro, M., Carretero, A., Nacher, V., Haurigot, V., George, M., Llombart, C., Casellas, A., Costa, C., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19478 · Cited by 175
Serum markers of oxidative stress and severity of diabetic retinopathy.
Hartnett, M. E., Stratton, R. D., Browne, R. W., Rosner, B. A., Lanham, R. J., & Armstrong, D. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.234 · Cited by 164
A thirty year journey in the polyol pathway
Kinoshita, J. H. (1990) · Experimental Eye Research · doi:10.1016/0014-4835(90)90096-d · Cited by 162
Advanced glycation end products and diabetic complications
Stitt, A. W., Jenkins, A. J., & Cooper, M. E. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.9.1205 · Cited by 162
Leukocytes in Diabetic Retinopathy
Chibber, R., Ben-Mahmud, B., Chibber, S., & Kohner, E. (2007) · Current Diabetes Reviews · doi:10.2174/157339907779802139 · Cited by 162
Self-citationCui, Y., Xu, X., Bi, H., Zhu, Q., Wu, J., Xia, X., Ren, Q., & Ho, P. C. P. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.03.024 · Cited by 159
Neurodegeneration: An early event of diabetic retinopathy
Villarroel, M. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i2.57 · Cited by 158
Coxon, A., BREADY, J. V., Min, H., Kaufman, S., Leal, J., Yu, D., Lee, T. A., Sun, J.-R., Estrada, J., Bolon, B. N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0213 · Cited by 158
Kador, P. F. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070110117035 · Cited by 154
Angiotensin and diabetic retinopathy
Wilkinson‐Berka, J. L. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.002 · Cited by 153
Aiello, L. P., Clermont, A. C., Arora, V. M., Davis, M. D., Sheetz, M. J., & Bursell, S. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0757 · Cited by 153
Thallas‐Bonke, V., Lindschau, C., Rizkalla, B., Bach, L. A., Boner, G., Meier, M., Haller, H. G., Cooper, M. E., & Forbes, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2921 · Cited by 151
Bates, D. O., & CURRY, F. E. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.2.h687 · Cited by 149
Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
Frank, R. N., Keirn, R., Kennedy, A., & Frank, K. W. (1983) · PubMed · Cited by 148
Funatsu, H., Yamashita, H., Nakanishi, Y., & Hori, S. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.3.311 · Cited by 146
Mancia, G. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0177-z · Cited by 137
Tadlock, L., Yamagiwa, Y., Hawker, J. R., Marienfeld, C. B., & Patel, T. C. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00550.2002 · Cited by 131
KIM, H., Barroso, M., Samanta, R., Greenberger, L. M., & Sztul, E. S. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.2.c687 · Cited by 129
Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C., & Lorenzi, M. (2006) · Diabetes · doi:10.2337/db06-0138 · Cited by 129
The Effect of Oxidation on Sorbitol Pathway Kinetics
Barnett, P. A., González, R. G., Chylack, L. T., & Cheng, H. (1986) · Diabetes · doi:10.2337/diab.35.4.426 · Cited by 121
den Enden, M. K. V., Nyengaard, J. R., Ostrow, E., Burgan, J., & Williamson, J. R. (1995) · PubMed · Cited by 120
Klein, R. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.172 · Cited by 118
Kowluru, R. A., Kern, T. S., Engerman, R. L., & Armstrong, D. (1996) · Diabetes · doi:10.2337/diab.45.9.1233 · Cited by 115
THE NATURAL HISTORY OF DIABETIC RETINOPATHY
Burditt, A. F., Caird, F. I., & Draper, G. J. (1968) · QJM · doi:10.1093/oxfordjournals.qjmed.a067145 · Cited by 114
Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes.
Otani, A., Takagi, H., Oh, H., Suzuma, K., Matsumura, M., Ikeda, E., & Honda, Y. (2000) · PubMed · Cited by 109
Angiopoietin concentrations in diabetic retinopathy
Patel, J. I. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.049940 · Cited by 109
Kowluru, A. (2001) · Acta Diabetologica · doi:10.1007/s592-001-8076-6 · Cited by 106
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation
Sfikakis, P. P., Grigoropoulos, V. G., Emfietzoglou, I., THEODOSSIADIS, G. P., Tentolouris, N., Delicha, E., Katsiari, C. G., Αλεξιάδου, Κ., Hatziagelaki, E. E., & Theodossiadis, P. G. (2010) · Diabetes Care · doi:10.2337/dc09-2372 · Cited by 103
Spijkerman, A. M. W., Gall, M. ‐., Tarnow, L., Twisk, J. W. R., Lauritzen, E., Lund‐Andersen, H., EMEIS, J. J., Parving, H. ‐., & Stehouwer, C. D. A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02217.x · Cited by 102
The Role of Growth Hormone, Insulin-Like Growth Factor and Somatostatin in Diabetic Retinopathy
Wilkinson‐Berka, J. L., Wraight, C. J., & Werther, G. A. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778773086 · Cited by 99
Drel, V. R., Pacher, P., Ali, T. K., Shin, J., Julius, U., El‐Remessy, A. B., & Obrosova, I. G. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.667 · Cited by 99
Park, K., Chen, Y., Hu, Y., Mayo, A. S., Kompella, U. B., Longeras, R., & Ma, J. (2009) · Diabetes · doi:10.2337/db08-1327 · Cited by 97
Novel Role of Mitochondrial Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy
Mohammad, G., & Kowluru, R. A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6368 · Cited by 95
Min, S.-H., Lee, T.-I., Chung, Y. S., & Kim, H. K. (2006) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2006.20.3.162 · Cited by 94
Ottiger, M., Thiel, M. A., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2372 · Cited by 85
PKC inhibition and diabetic microvascular complications
Clarke, M., & Dodson, P. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.007 · Cited by 85
Amano, S., Yamagishi, S., Inagaki, Y., Nakamura, K., Takeuchi, M., Inoue, H., & Imaizumi, T. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.11.001 · Cited by 84
Inhibition of Protein Kinase C δ Attenuates Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
Kim, J. H., Kim, J. H., Jun, H.-O., Yu, Y. S., & Kim, K.-W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090398 · Cited by 80
The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes
Miwa, K., Nakamura, J., Hamada, Y., Naruse, K., Nakashima, E., Kato, K., Kasuya, Y., Yasuda, Y., Kamiya, H., & Hotta, N. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00248-6 · Cited by 76
Aldose reductase and polyol in cultured pericytes of human retinal capillaries
Hohman, T. C., Nishimura, C., & Robison, W. G. (1989) · Experimental Eye Research · doi:10.1016/0014-4835(89)90018-3 · Cited by 75
Blood pressure control and diabetic retinopathy
Klein, R., & Klein, B. E. K. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.365 · Cited by 74
Pharmacotherapy for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000143685.60479.3b · Cited by 74
Beltramo, E., Berrone, E., Buttiglieri, S., & Porta, M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.470 · Cited by 72
Armstrong, D., Ueda, T., Ueda, T., Aljada, A., Browne, R. W., Fukuda, S., Spengler, R., Chou, R., Hartnett, M. E., Buch, P. S., et al. (1998) · Angiogenesis · doi:10.1023/a:1009010628371 · Cited by 68
Praidou, A., Klangas, I., Papakonstantinou, E., et al. (2009) · Current Eye Research · doi:10.1080/02713680802585920 · Cited by 66
Takami, S., Yamashita, S., Kihara, S., Kameda-Takemura, K., & Matsuzawa, Y. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00286-4 · Cited by 66
Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown
Haurigot, V., Villacampa, P., Ribera, A., Llombart, C., Bosch, A., Nacher, V., Ramos, D., Ayuso, E., Segovia, J. C., Bueren, J. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014787 · Cited by 66
Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes
Amano, S., Yamagishi, S., Kato, N., Inagaki, Y., Okamoto, T., Makino, M., Taniko, K., Hirooka, H., Jomori, T., & Takeuchi, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02584-6 · Cited by 60
Joy, S. V., Scates, A. C., Bearelly, S., Dar, M. S., Taulien, C. A., Goebel, J. A., & Cooney, M. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e572 · Cited by 60
Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats
Roy, S., & Lorenzi, M. (1996) · Diabetologia · doi:10.1007/bf00418547 · Cited by 56
Kato, N., Yashima, S., Suzuki, T., Nakayama, Y., & Jomori, T. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00193-9 · Cited by 56
Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids
Hammes, H. P., Weiss, A., F�hrer, D., Kr�mer, H. J., Papavassilis, C., & Grimminger, F. (1996) · Diabetologia · doi:10.1007/bf00418338 · Cited by 50
Ultrastructural Features of Retinal Capillary Basement Membrane Thickening in Diabetic Swine
Lee, S. E., Ma, W., Rattigan, E. M., Aleshin, A. N., Chen, L., Johnson, L. L., D’Agati, V. D., Schmidt, A., & Barile, G. R. (2010) · Ultrastructural Pathology · doi:10.3109/01913120903308583 · Cited by 47
Chibber, R., Ben-Mahmud, B. M., Mann, G. E., Zhang, J. J., & KOHNER, E. M. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1519 · Cited by 41
Self-citationLightman, S., Rechthand, E., Terubayashi, H., Palestine, A. G., Rapoport, S. I., & Kador, P. F. (1987) · Diabetes · doi:10.2337/diab.36.11.1271 · Cited by 40
Chibber, R., Ben-Mahmud, B. M., Coppini, D. V., Christ, E., & Kohner, E. M. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1724 · Cited by 40
Self-citationZhang, X., Wen, L., Yan-jiong, C. H. E. N., & Zhu, Y. (2009) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2009.03.019 · Cited by 39
Ben-Mahmud, B. M., Mann, G. E., Datti, A., Orlacchio, A., KOHNER, E. M., & Chibber, R. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2968 · Cited by 39
Self-citationChibber, R., Pa, M., & KOHNER, E. M. (1999) · PubMed · Cited by 38
Self-citationHyer, S. L., Sharp, P., Sleightholm, M. A., Burrin, J. M., & KOHNER, E. M. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009140 · Cited by 33
Self-citationCusick, M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1745 · Cited by 31
Hattori, T., Matsubara, A., Taniguchi, K., & Ogura, Y. (2010) · Current Eye Research · doi:10.3109/02713680903447918 · Cited by 27
Zhang, W., & Hu, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.031 · Cited by 24
Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy
Amano, S., Yamagishi, S., Koda, Y., et al. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00013-6 · Cited by 22
Akita, M., Mizuno, K., Matsubara, A., et al. (1993) · PubMed · doi:10.18926/amo/31580 · Cited by 9
Retinal Capillary Dilation: Early Diabetic-Like Retinopathy in the Galactose-Fed Rat Model
Glover, J. P., JACOT, J. L., Basso, M., et al. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.167 · Cited by 7
Cited by
Kang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Vascular Complications of Diabetes
Beckman, J. A., & Creager, M. A. (2016) · Circulation Research · doi:10.1161/circresaha.115.306884 · Cited by 412
Metadata
- Authors
- Tarr, J. M., Kaul, K., Chopra, M., Kohner, E. M., & Chibber, R.
- Venue
- ISRN Ophthalmology
- Publisher
- Hindawi Limited
- Published
- 2013-01-15
- Volume
- 2013
- Pages
- 1-13
- ISSN
- 2090-5688 (ISSN-L)
- 2090-5696
- OpenAlex
- W2031740343
- Cited by
- 455
- References
- 138
- FWCI
- 31.02
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.